Expanded Access Program For Insmed’s Iplex Shows Power Of Patient Advocates At FDA
This article was originally published in The Pink Sheet Daily
Executive Summary
Lou Gehrig’s patients who appealed to the agency early will get access to drug; others enter a lottery system as part of a clinical trial.